Inflammatory breast cancer in North Africa: Comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco

Breast Disease

Volumn 33, Issue 4, 2011, Pages 159-169

  Soliman, Amr S ^a   Kleer, Celina G ^b   Mrad, Karima ^c   Karkouri, Mehdi ^d   Omar, Sherif ^e   Khaled, Hussein M ^e   Benider, Abdel Latif ^d   Ayed, Farhat Ben ^f   Eissa, Saad S ^e   Eissa, Mohab S ^a   McSpadden, Erin J ^a   Lo, An Chi ^a   Toy, Kathy ^b   Kantor, Elizabeth D ^a   Xiao, Quin ^a   Hampton, Claire ^a   Merajver, Sofia D ^b,g  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SALAH AZAIEZ INSTITUTE   (Tunisia)

^d HASSAN II UNIVERSITY   (Morocco)

^e CAIRO UNIVERSITY   (Egypt)

^f Anti cancer Foundation   (Tunisia)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Egypt; Inflammatory breast cancer; Morocco; North Africa; RhoC; tumor emboli; Tunisia

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EDEMA; EGYPT; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY BREAST CANCER; MAJOR CLINICAL STUDY; METASTASIS; MOLECULAR EPIDEMIOLOGY; MOROCCO; ONCOLOGICAL PARAMETERS; PEAU D' ORANGE; PRIORITY JOURNAL; TUMOR EMBOLISM; TUNISIA;

ADULT; AGE FACTORS; AGED; EGYPT; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOROCCO; NEOPLASTIC CELLS, CIRCULATING; RHO GTP-BINDING PROTEINS; TUNISIA;

EID: 84876219796     PISSN: 08886008     EISSN: 15581551     Source Type: Journal    
DOI: 10.3233/BD-2012-000337     Document Type: Article

References (34)

1. M.A. Abolfotouh, L.A. Soliman, E. Mansour et al., Central obesity among adults in Egypt: prevalence and associated morbidity, East Mediterr Health J 14 (2008), 57-68. (Pubitemid 351753092)
2. W.F. Anderson, C. Schairer, B.E. Chen et al., Epidemiology of inflammatory breast cancer (IBC), Breast Dis 22 (2005), 9-23. (Pubitemid 44308938)
3. A. Batnitzky, Obesity and household roles: gender and social class in Morocco, Sociol Health Illn 30 (2008), 445-462.
4. L. Beltaifa, P. Traissac, J. El Ati et al., Prevalence of obesity and associated socioeconomic factors among Tunisian women from different living environments, Obes Rev 10 (2009), 145-153.
5. H. Boussen, H. Bouzaiene, J. Ben Hassouna et al., Inflammatory breast cancer in Tunisia: Reassessment of incidence and clinicopathological features, Semin Oncol 35 (2008), 17-24. (Pubitemid 351282397)
6. H.L. Brooks, N. Mandava, W.F. Pizzi and S. Shah, Inflammatory breast carcinoma: A community hospital experience, J Am Coll Surg 186 (1998), 622-629. (Pubitemid 28278247)
7. S. Chang, S.L. Parker, T. Pham et al., Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992, Cancer 82 (1998), 2366-2372. (Pubitemid 28283443)
8. M. Cristofanilli, E.S. Singletary and G.N. Hortobagyi, Inflammatory breast carcinoma: the sphinx of breast cancer research, J Clin Oncol 22 (2004), 381-3; author reply 383.
9. F.L. Greene, D.L. Page, A. Fritz et al., Breast, in: AJCC Cancer Staging Manual, (6th ed.), F.L. Greene, American Joint Committee on Cancer. and American Cancer Society., eds., Springer-Verlag, New York, 2002, pp. 223-240.
10. G. Gruber, M. Ciriolo, H.J. Altermatt et al., Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer, Int J Cancer 109 (2004), 144-148. (Pubitemid 38160675)
11. K.W. Hance, W.F. Anderson, S.S. Devesa et al., Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute, J Natl Cancer Inst 97 (2005), 966-975. (Pubitemid 41430562)
12. C.G. Kleer, K.A. Griffith, M.S. Sabel et al., RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast, Breast Cancer Res Treat 93 (2005), 101-110. (Pubitemid 41396771)
13. C.G. Kleer, K.L. van Golen, Y. Zhang et al., Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability, Am J Pathol 160 (2002), 579-584. (Pubitemid 34160335)
14. C.G. Kleer, Y. Zhang, Q. Pan et al., WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer, Breast Cancer Res 6 (2004), R110-5.
15. M.G. Le, R. Arriagada, J. Bahi et al., Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer Breast 15 (2006), 355-362. (Pubitemid 43832575)
16. M.G. Le, R. Arriagada, G. Contesso et al., Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: A French-Tunisian joint study in 337 patients, Clin Breast Cancer 6 (2005), 439-445. (Pubitemid 43078900)
17. P.H. Levine, B.G. Pogo, A. Klouj et al., Increasing evidence for a human breast carcinoma virus with geographic differences, Cancer 101 (2004), 721-726. (Pubitemid 39030926)
18. P.H. Levine, S.C. Steinhorn, L.G. Ries and J.L. Aron, Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program, J Natl Cancer Inst 74 (1985), 291-297. (Pubitemid 15112115)
19. A.C. Lo,A.Georgopoulos, C.G.Kleer et al., Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients, Breast 18 (2009), 55-59.
20. A.C. Lo, C.G. Kleer, M. Banerjee et al., Molecular epidemiologic features of inflammatory breast cancer: A comparison between Egyptian and US patients, Breast Cancer Res Treat 112 (2008), 141-147.
21. M. Maalej, H. Frikha, S. Ben Salem et al., Breast cancer in Tunisia: Clinical and epidemiological study, Bull Cancer 86 (1999), 302-306. (Pubitemid 29196091)
22. R. Marrakchi, I. Khadimallah, S. Ouerhani et al., Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients, Cancer Invest 28 (2010), 399-407.
23. S.D. Merajver, V.L. Goodman and M.S. Sabel, Inflammatory breast cancer: Advances in molecular genetics and treatment, in: Textbook of Breast Cancer: A Clinical Guide to Therapy, (3rd ed.), G. Bonadonna, G.N. Hortobagyi and P. Valagussa, eds, Taylor and Francis, London [u.a.], 2006, pp. 241-256.
24. S. Omar, H. Khaled, R. Gaafar et al., Breast cancer in Egypt: A review of disease presentation and detection strategies, East Mediterr Health J 9 (2003), 448-463. (Pubitemid 40521212)
25. D.M. Renz, P.A. Baltzer, J. Bottcher et al., Inflammatory breast carcinoma in magnetic resonance imaging: A comparison with locally advanced breast cancer, Acad Radiol 15 (2008), 209-221.
26. G. Samuelson, Physical Status: The Use and Interpretation of Anthropometry. WHO Technical Report Series, Acta Pædiatrica 86 (1997), 280-280.
27. A.S. Soliman, M. Banerjee, A.C. Lo et al., High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt, Breast J 15 (2009), 432-434.
28. A.S. Soliman, S.V. Vulimiri, H.E. Kleiner et al., High levels of oxidativeDNAdamage in lymphocyteDNAof premenopausal breast cancer patients from Egypt, Int J Environ Health Res 14 (2004), 121-134. (Pubitemid 38510054)
29. A.S. Soliman, X. Wang, J. DiGiovanni et al., Serum organochlorine levels and history of lactation in Egypt, Environ Res 92 (2003), 110-117. (Pubitemid 36875706)
30. I. Van der Auwera, G.G. Van den Eynden, C.G. Colpaert et al., Tumor lymphangiogenesis in inflammatory breast carcinoma: Ahistomorphometric study, Clin Cancer Res 11 (2005), 7637-7642. (Pubitemid 41611604)
31. K.L. vanGolen, S.Davies, Z.F.Wu et al.,Anovel putative lowaffinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype, Clin Cancer Res 5 (1999), 2511-2519. (Pubitemid 29437336)
32. J.M.Walshe and S.M. Swain, Clinical aspects of inflammatory breast cancer, Breast Dis 22 (2005), 35-44. (Pubitemid 44308940)
33. P.A. Wingo, P.M. Jamison, J.L. Young and P. Gargiullo, Population-based statistics for women diagnosed with inflammatory breast cancer (United States), Cancer Causes Control 15 (2004), 321-328. (Pubitemid 38988041)
34. M. Wu and S.D. Merajver, Molecular biology of inflammatory breast cancer: Applications to diagnosis, prognosis, and therapy, Breast Dis 22 (2005), 25-34. (Pubitemid 44308939)